Complement pathway activity in the opsonization of cefotaxime-treated Escherichia coli by normal human serum.
Shaio
M F
MF
Chang
F Y
FY
Chou
M Y
MY
D002439:Cefotaxime / Q000494:pharmacology*; D003167:Complement Activation / Q000187:drug effects*; D003171:Complement Pathway, Classical / Q000187:drug effects*; D004926:Escherichia coli; D006801:Humans; D066298:In Vitro Techniques; D010587:Phagocytosis
D002439:Cefotaxime